149 related articles for article (PubMed ID: 29504987)
1. Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma: A case report and review of the literature.
Spetsieris N; Giannakopoulou N; Variami E; Zervakis K; Rougala N; Garefalakis G; Skarlatou V; Viniou NA; Diamantopoulos P
Medicine (Baltimore); 2018 Jan; 97(3):e9608. PubMed ID: 29504987
[TBL] [Abstract][Full Text] [Related]
2. Imaging features of skeletal muscle lymphoma: a case report and literature review.
Gao S; Shu H; Yang H
BMC Med Imaging; 2021 Sep; 21(1):136. PubMed ID: 34565344
[TBL] [Abstract][Full Text] [Related]
3. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
Yang X; Min X; He W
Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
[TBL] [Abstract][Full Text] [Related]
4. Primary extranodal lymphoma of skeletal muscles: a report of four cases.
Bertoni F; Sanna P; Zucca E; Roggero E; Cavalli F
Oncol Rep; 1998; 5(3):605-7. PubMed ID: 9538160
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of primary skeletal muscle lymphoma, and a review of the literature].
Ueno A; Kuribayashi K; Iyama S; Matsunaga T; Kikuchi S; Sato T; Kobune M; Takimoto R; Kato J; Niitsu Y
Rinsho Ketsueki; 2005 Oct; 46(10):1141-5. PubMed ID: 16440778
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
Wang C; Li W; Liu C; He H; Bai O
Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
Zheng SM; Zhou DJ; Chen YH; Jiang R; Wang YX; Zhang Y; Xue HL; Wang HQ; Mou D; Zeng WZ
World J Gastroenterol; 2017 Jun; 23(24):4467-4472. PubMed ID: 28706431
[TBL] [Abstract][Full Text] [Related]
8. A Case Report of Primary Extranodal Diffuse Large B-Cell Lymphoma Involving the Masseter Muscle: Histological-Radiological Correlation.
Lim S; Baek HJ; Kang YH
Curr Med Imaging; 2023; 19(7):788-794. PubMed ID: 36056840
[TBL] [Abstract][Full Text] [Related]
9. [Clinical manifestation and treatment of extranodal diffuse large B-cell lymphoma].
Tomita N
Rinsho Ketsueki; 2016; 57(10):1991-1999. PubMed ID: 27725597
[TBL] [Abstract][Full Text] [Related]
10. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
11. Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era.
Gutiérrez-García G; Colomo L; Villamor N; Arenillas L; Martínez A; Cardesa T; García-Herrera A; Setoain X; Rodríguez S; Ghita G; Abrisqueta P; Giné E; Bosch F; Campo E; Montserrat E; López-Guillermo A
Leuk Lymphoma; 2010 Jul; 51(7):1225-32. PubMed ID: 20497002
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma.
Abdulla M; Guglielmo P; Hollander P; Åström G; Ahlström H; Enblad G; Amini RM
Eur J Haematol; 2020 Mar; 104(3):207-213. PubMed ID: 31785002
[TBL] [Abstract][Full Text] [Related]
13. Diffuse large B-cell lymphoma.
Martelli M; Ferreri AJ; Agostinelli C; Di Rocco A; Pfreundschuh M; Pileri SA
Crit Rev Oncol Hematol; 2013 Aug; 87(2):146-71. PubMed ID: 23375551
[TBL] [Abstract][Full Text] [Related]
14. Extranodal site of diffuse large B-cell lymphoma and the risk of R-CHOP chemotherapy resistance and early relapse.
Ting CY; Gan GG; Bee-Lan Ong D; Tan SY; Bee PC
Int J Clin Pract; 2020 Oct; 74(10):e13594. PubMed ID: 32583545
[TBL] [Abstract][Full Text] [Related]
15. Primary diffuse large B-cell lymphoma in the maxilla: A case report.
Zou H; Yang H; Zou Y; Lei L; Song L
Medicine (Baltimore); 2018 May; 97(20):e10707. PubMed ID: 29768336
[TBL] [Abstract][Full Text] [Related]
16. CLINICAL CHARACTERISTICS OF PRIMARY EXTRANODAL VERSUS NODAL DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE COHORT STUDY IN A CANCER CENTER.
Candelaria M; Oñate-Ocaña LF; Corona-Herrera J; Barrera-Carmona C; Ponce-Martínez M; Gutiérrez-Hernández O; Avilés-Salas A; Cacho-Díaz B
Rev Invest Clin; 2019; 71(5):349-358. PubMed ID: 31599881
[TBL] [Abstract][Full Text] [Related]
17. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous involvement in diffuse large B cell lymphoma at presentation: report of two rare cases and literature review.
Kilaru S; Panda SS; Mishra S; Mohapatra D; Baisakh M; Kolluri S; Devaraj S; Moharana L; Biswas G
J Egypt Natl Canc Inst; 2021 Sep; 33(1):25. PubMed ID: 34514544
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z
Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255
[TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
